Vancouver hospital signs deal with genomics firm at ‘leading edge of medicine’
A promising future’s in the genes for St. Paul’s Hospital and a team of Vancouver medical researchers who signed a research deal with the world’s largest genomics company on Wednesday.
China’s BGI — which has pioneered treatments tailored to each individual patient’s genetic code — signed a memorandum of understanding with several B.C. health organizations to further the study of the cutting-edge approach to medicine.
It could revolutionize how doctors approach hard-to-treat conditions, particularly cancer.
David P. Ball reports
Dianne Doyle, President & CEO, and Geoff Plant, Chair, PHC Board of Directors